M E D I C U S - Shoqata e Mjekëve Shqiptarë të Maqedonisë-Hipokrati
M E D I C U S - Shoqata e Mjekëve Shqiptarë të Maqedonisë-Hipokrati M E D I C U S - Shoqata e Mjekëve Shqiptarë të Maqedonisë-Hipokrati
Figure 4. Trisomy 18, ultrasonography of the central nervous system at the age of 3 days showing 2 nd degree intracranial hemorrhage with periventricular leucomalation, a chorioid plexus cyst and dilated posterior cranial fossa at the level of cistern magna. DISCUSSION The reported prevalence of trisomy 18 varies greatly and reflects the way in which data are collected (2, 6). The postnatal survival depends on the level and intensity of care provided with prolonged median survival times when intensive care measures and intensive cardiac management (pharmacological intervention for ductal patency and palliative or corrective surgery for congenital heart defects) is applied (4. 10, 11). These data of improved survival, through neonatal intensive treatment, are helpful for clinicians to offer the best information on treatment options to families of patients with trisomy 18 (4). In our two cases different strategies are applied. In Case 1, after the initial stabilization, the parents were advised on the possibility for cardiac surgery intervention, but the parents opted to withhold from operation, therefore conservative care was provided until death. In Case 2, although intensive care measures were provided, longer survival was compromised due to the complexity of the cardiopathy and the severity of the condition. These two cases have similar family history, being first children from wanted and followed up pregnancies in families of young parents with no apparent pregnancy complications. In the first trimester, two serum markers can be tested for prenatal screening of aneuploidies: pregnancy-associated plasma protein-A, a large glycoprotein tetramer, and free beta-human chorionic gonadotropin (beta-hCG), 1 of the 2 subunits of the glycoprotein hormone Hcg (12, 13, 14). The multiple marker combination in the second trimester with the highest screening performance is alphafetoprotein (AFP), unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and inhibin A, together with maternal age (so-called quad marker test) (15). It is found that first trimester screening protocols for Down syndrome (nuchal translucency combined with biochemical markers) can detect the majority of non-Down syndrome aneuploidies, with a detection rate of 78% with even a higher rate of detection when second trimester markers are applied (13). However, in both our cases prenatal diagnosis (first or second trimester biochemical screening and/or amniocentesis) was not offered to the parents due to the young maternal age. Fetal echocardiography can reliably detect congenital heart disease as early as 12 weeks gestation, at the time of of nuchal translucency measurement
(7, 9). Congenital heart disease is found in up to 95% of patients with trisomy 18 (2, 9). Although ultrasonography is broadly applied during pregnancy, the percentage of detection of congenital cardiopathies is still low in our country. In a recent domestic epidemiologic study performed none of the 44 prospectively followed up cases of congenital cardiopathies was prenataly suspected so have a congenital heart defect (16). If a reverse approach is applied, whenever a congenital cardiopathy is diagnosed on fetal ultrasonography, chromosomal anomaly has to be excluded by amniocentesis due to the high proportion of associated findings (17). Both cases in the present study had common trisomy 18 with a kariotype 47, XY+18 in the first case and 47, XX+18 in case 2. Nevertheless, clinical features in both cases varied significantly. Some of the common features in both cases were: growth restriction, congenital heart defect, low-set ears, short neck, and retrognatia. The cases presented here represent a reminder for the clinician in terms of appropriate prenatal diagnosis and genetic counseling. Increased awareness of this condition is also necessary in the early neonatal period, due to its variable clinical expression and serious course and outcome. CONCLUSION Fetal ultrasonography screening should be able to identify most cases of trisomy 18 with detectable congenital heart defects and prompt further diagnostic workup (amniocentesis and kariotype) even in a non-risk population (mother
- Page 191 and 192: FAKTORËT PREDISPOZUES TË PNEUMONI
- Page 193 and 194: variable të shpërndarë normalish
- Page 195 and 196: përdorur kritere specifike për t
- Page 197 and 198: Key words : mechanical ventilation,
- Page 199 and 200: Sëmundjet kronike janë konfirmuar
- Page 201 and 202: DIURETIKËT ANTIDIABETIKËT KARDIOT
- Page 203 and 204: Nga tabela 3 vijmë në përfundim
- Page 205 and 206: Frakturat osteoporotike mbesin prob
- Page 207 and 208: 15. Gurwitz JH, Soumerai SB, Avorn
- Page 209 and 210: pove}eto dejnosti, a vo mnogu slu~a
- Page 211 and 212: Od vkupniot broj na slepi lica koj
- Page 213 and 214: Tabela 2. sledat onie na vozrast od
- Page 215 and 216: 10 Etiolo{kiot faktor se razgleduva
- Page 217 and 218: Od navedite rezultati, se zabele`uv
- Page 219 and 220: SUMMARY THE CAUSES OF BLINDNESS IN
- Page 221 and 222: ezi i supeve, për shkak të vësht
- Page 223 and 224: Në tab. 2 janë prezentuar faktor
- Page 225 and 226: Sipas autorëve polak (2,3) inciden
- Page 227 and 228: Shtatzania e shumëfishtë, pesha e
- Page 229 and 230: Marija Saboli}-Asenova 1 , Vesna Sa
- Page 231 and 232: Figura 1. Prisatni visokovoltirani
- Page 233 and 234: emenosta. Razli~ni se mislewata i z
- Page 235 and 236: Vigabatrin (VGB). The diagnosis was
- Page 237 and 238: konsekuenca dëmtuese në funkcioni
- Page 239 and 240: the common features in both cases a
- Page 241: Figure 2. Several of the common ano
- Page 245 and 246: Универзитетска Кли
- Page 247 and 248: Nën lëkurë është shtresa e ind
- Page 249 and 250: Gjatë operacionit Në përfundim t
- Page 251 and 252: Defekti i krijuar pas heqjes së tu
- Page 253 and 254: 3. Borah GL, Hidalgo DA, Wey PD: Re
- Page 255 and 256: RESUME Background: Marfan's Syndrom
- Page 257 and 258: Figure 3 Here ... Figure 3 a- Right
- Page 259 and 260: 4. Hindle NW, Crawford JS: Dislocat
- Page 261 and 262: Antibiotikët shkaktojnë problem n
- Page 263 and 264: Ketokonazole alkaloid® (Alkaloid),
- Page 265 and 266: Levonelle® (Schering), tableta 0,7
- Page 267 and 268: REZYME: Bioteknologjia ka aplikim t
- Page 269 and 270: • ADN-biblioteka Figura 1 Qëllim
- Page 271 and 272: • Fibroza kistike është çrregu
- Page 273 and 274: PËRFUNDIMI Figura 2 Bioteknologjia
- Page 275 and 276: Tel.++38970 207 350, ++38976 425 47
- Page 277 and 278: Во 70 до 90% од испита
- Page 279 and 280: психијатар, се до н
- Page 281 and 282: this integration of forensic psychi
- Page 283 and 284: Etika mjekësore cakton standarde m
- Page 285 and 286: Dr. sci. Agron M. Rexhepi DORACAK A
- Page 287 and 288: Përgatitja teknike e shkëlqyeshme
- Page 289 and 290: pranishmit i përshëndeti dhe u d
- Page 291 and 292: � Florence LUSTMAN, inspector gen
(7, 9). Congenital heart disease is found in up to 95% of patients with trisomy 18 (2, 9).<br />
Although ultrasonography is broadly applied during pregnancy, the percentage of<br />
detection of congenital cardiopathies is still low in our country. In a recent domestic<br />
epidemiologic study performed none of the 44 prospectively followed up cases of<br />
congenital cardiopathies was prenataly suspected so have a congenital heart defect (16).<br />
If a reverse approach is applied, whenever a congenital cardiopathy is diagnosed on fetal<br />
ultrasonography, chromosomal anomaly has to be excluded by amniocentesis due to the<br />
high proportion of associated findings (17). Both cases in the present study had common<br />
trisomy 18 with a kariotype 47, XY+18 in the first case and 47, XX+18 in case 2.<br />
Nevertheless, clinical features in both cases varied significantly. Some of the common<br />
features in both cases were: growth restriction, congenital heart defect, low-set ears, short<br />
neck, and retrognatia. The cases presented here represent a reminder for the clinician in<br />
terms of appropriate prenatal diagnosis and genetic counseling. Increased awareness of<br />
this condition is also necessary in the early neonatal period, due to its variable clinical<br />
expression and serious course and outcome.<br />
CONCLUSION<br />
Fetal ultrasonography screening should be able to identify most cases of trisomy<br />
18 with detectable congenital heart defects and prompt further diagnostic workup<br />
(amniocentesis and kariotype) even in a non-risk population (mother